Five groups of weaner pigs were intranasally inoculated with constant doses of bovine viral diarrhoea virus (BVDV) strain OSLOSS/2482. Four weeks post primary inoculation (p.p.i.) the animals were intranasally challenged with decreasing doses of hog cholera virus (HCV) strain Alfort/187. Clinical signs were not observed apart from a short febrile period (2 days, > 40 degrees C) in one animal. Another animal died intercurrently without showing any pathological signs. Virus isolation from leucocyte samples taken regularly during one week post challenge detected HC viraemia in most animals that had received HCV doses > 100 TCID50 per animal. Using monoclonal antibody (mab) analysis all isolates obtained were proven to be HCV. Serological investigations using the virus neutralization test (VNT) yielded HC neutralizing antibodies in all groups with higher titres in those animals having received HCV doses > 100 TCID50. However, HCV specific neutralizing antibodies never exceeded the BVDV antibody titre. A complex trapping blocking (CTB) ELISA applying a HCV specific mab detected HCV specific antibodies in animals that had gone through HC viraemia while discriminating BVDV specific antibodies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1439-0450.1993.tb00108.x | DOI Listing |
Asian J Transfus Sci
August 2024
Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Introduction: Hemoglobin (Hb) estimation in blood donors is conducted using capillary samples on portable hemoglobinometers, representing measurement methods in practice. The reference standard is conducted using a venous sample on a hematology analyzer, representing the mentor measurement method or the true value. The correction involves the calculation of the secondary adjustment factor (SAF) to mitigate the difference between the two values.
View Article and Find Full Text PDFLiver Int
February 2025
Roger Williams Institute of Liver Studies, Foundation for Liver Research, London, UK.
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) encompasses a spectrum of histological conditions ranging from simple steatosis to fibrosing steatohepatitis, and is a risk factor for cardiovascular diseases (CVD). While oxidised apolipoproteins A and B have been linked to obesity and CVD, the association between other oxidised apolipoproteins and MASLD is yet to be established. To fill this gap, we characterised the circulating serum peptidome of patients with MASLD.
View Article and Find Full Text PDFHepatology
January 2025
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Preventive interventions are expected to substantially improve the prognosis of patients with primary liver cancer, predominantly hepatocellular carcinoma (HCC) and cholangiocarcinoma. HCC prevention is challenging in the face of the evolving etiological landscape, particularly the sharp increase in obesity-associated metabolic disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD). Next-generation anti-HCV and HBV drugs have substantially reduced, but not eliminated, the risk of HCC and have given way to new challenges in identifying at-risk patients.
View Article and Find Full Text PDFBackground: Due to the unique geographical and climatic conditions in Nagqu (Tibet), the blood station laboratory was only fully established and accredited by 2020. This study validated the performance of the laboratory's blood screening system and analyzed recent trends in blood donation and screening effectiveness.
Methods: Various serum samples were used to assess the performance of hepatitis B, hepatitis C, HIV, and syphilis tests, both serological and nucleic acid tests.
Euroasian J Hepatogastroenterol
December 2024
Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Introduction: One of the main causes of primary hepatocellular carcinoma and chronic hepatitis is the hepatitis C virus (HCV), with significant variability in its genotypes affecting pathogenicity and treatment outcomes. In India, prevalence ranges from 0.5 to 1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!